Related Experiment Video
Updated: Dec 16, 2025
08:22
In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
Published on: October 27, 2020
3.4K
Warm Blood Cardioplegia for Myocardial Protection: Concepts and Controversies
Taylor M James1, Marcos Nores2, John A Rousou3
1Graduate Medical Education MD/MPH Program, University of Miami Miller School of Medicine, Miami, Florida 33130.
Texas Heart Institute Journal
|July 1, 2020
Summary
Warm blood cardioplegia offers safe and effective myocardial protection during heart surgery. Despite ongoing debate, research supports its suitability for cardiopulmonary bypass procedures.
Area of Science:
- Cardiovascular Surgery
- Cardiothoracic Anesthesia
- Cardiac Physiology
Background:
- Warm blood cardioplegia has been utilized since the 1990s.
- Its efficacy in myocardial protection remains a subject of debate.
- Understanding the physiologic and technical aspects is crucial.
Purpose of the Study:
- To review the physiologic and technical principles of warm blood cardioplegia.
- To summarize current basic and clinical research on its effectiveness.
- To discuss controversies surrounding its use in cardiac surgery.
Main Methods:
- Literature review of experimental and clinical studies.
- Analysis of physiologic data related to myocardial protection.
- Examination of technical aspects of warm blood cardioplegia delivery.
Main Results:
- Extensive experimental data supports the safety and efficacy of warm blood cardioplegia.
- Clinical research indicates its suitability for myocardial protection.
- Controversies exist but are often outweighed by evidence of effectiveness.
Conclusions:
- Warm blood cardioplegia is a safe and effective method for myocardial protection.
- It is suitable for use during cardiopulmonary bypass surgeries.
- Further research and discussion can help resolve remaining controversies.
Related Concept Videos
01:21Myocarditis I: Introduction
253
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
253
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
252
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
252
01:30Cardiomyopathy II: Dilated Cardiomyopathy
311
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
311
01:29Cardiomyopathy V: Interprofessional Care
204
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
204
01:29Cardiomyopathy VI: Nursing Management
212
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
212
01:14Myocarditis III: Medical Management
108
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
108